Your time horizon is important when comparing the performance of different stocks. Gilead Sciences (NASDAQ: GILD), for example, handily beat Pfizer (NYSE: PFE) over the past five years. But Pfizer is the bigger winner over the last 12 months.
However, when picking a stock, past performance isn’t nearly as important as what the future might hold. Which of these two drug stocks has an edge looking down the road? Here’s what the outlooks are for Gilead Sciences and Pfizer.
Image source: Getty Images.